Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Parinvest

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 1
Rounds per year 0.11
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 1
Key employees 1

Areas of investment

  • Biopharma
  • Neuroscience
  • Biotechnology
  • Medical
  • Pharmaceutical
Summary

In 2003 was created Parinvest, which is appeared as VC. The venture was found in North America in United States. The main office of represented VC is situated in the Miami.

Among the most successful fund investment fields, there are Biotechnology, Biopharma. For fund there is no match between the country of its foundation and the country of its the most frequent investments - France. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Pharnext

The overall number of key employees were 1.

The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Parinvest, startups are often financed by Truffle Capital, Financiu00e8re Boscary, Aurinvest. The meaningful sponsors for the fund in investment in the same round are Truffle Capital. In the next rounds fund is usually obtained by Truffle Capital.

The higher amount of exits for fund were in 2016. The important activity for fund was in 2012. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Parinvest:
Typical Co-investors
Parinvest is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Parinvest:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BioM AG -
Fuji Creative Japan, Koto
ICICI Prudential Life Insurance India, Maharashtra, Mumbai
KFintech Andhra Pradesh, Hyderabad, India
Lixin Touzi Chengguan District, China, Lhasa
Solera Capital New York, New York, United States
The Helm New York, New York, United States
Tigermed China, Hangzhou, Zhejiang
Uni-M Ventures -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Pharnext

Biopharma
Biotechnology
Medical
Neuroscience
Pharmaceutical
$2M08 Sep 2011 Ile-de-France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Parinvest?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 6M
Rounds per year 0.11
Peak activity year 2011
Lead investments 0
Follow on index 0.50
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Pharnext

Biopharma
Biotechnology
Medical
Neuroscience
Pharmaceutical
$2M08 Sep 2011 Ile-de-France
Crunchbase icon

Content report

The following text will be sent to our editors: